English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    you are here: HomeNewsCipla limited
    cipla limited
    Jump to
    • Cipla Q3 Result | Profit rises 10% YoY to Rs 801 crore, revenue up 6% January 25, 2023 04:27 PM IST

      Cipla Q3 Result | Profit rises 10% YoY to Rs 801 crore, revenue up 6%

      Revenues were aided by strong growth in US business supported by sustained traction in Indian business.

    • Cipla Q3 preview | Consolidated net profit likely to rise 22% YoY January 25, 2023 10:08 AM IST

      Cipla Q3 preview | Consolidated net profit likely to rise 22% YoY

      Cipla’s generic version of Revlimid may reinforce sales in the US and improve the EBITDA margin on a yearly basis

    • India Inc throws up a mixed bag in Q2 amid global headwinds, local play stays strong November 10, 2022 09:24 AM IST

      India Inc throws up a mixed bag in Q2 amid global headwinds, local play stays strong

      Excluding global cyclicals, profits of the Nifty50 companies would have grown 25 percent on-year, while, excluding BFSI companies, profits would have decreased 14 percent, say analysts

    • Cipla beats estimate, net profit rises 10.9% on-year in Q2 November 04, 2022 03:48 PM IST

      Cipla beats estimate, net profit rises 10.9% on-year in Q2

      The drugmaker reported a 5.6 percent on-year rise in consolidated revenue from operations to Rs 5,828.4 crore

    • Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY November 03, 2022 05:44 PM IST

      Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY

      In the year-ago quarter, Cipla benefitted from the surge in sales of COVID-19-related drugs

    • Brokerage recommendations for Samvat 2079 October 22, 2022 07:23 AM IST

      Brokerage recommendations for Samvat 2079

      Kotak Securities, ICICI Securities and JM Financials suggest stocks that can generate returns of ~10 – 30 percent over the next 12 months

    • Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2% July 29, 2022 05:30 PM IST

      Cipla Q1 Result | Consolidated profit declines 4% YoY to Rs 686 crore; revenue dips 2%

      The company witnessed strong traction in its India and US businesses while the quarter was a subdued one for its business in SAGA (South Africa, Sub-Saharan Africa and Global Access) region.

    • Cipla Q1 Preview | Profit may decline 10% YoY on flat revenue July 28, 2022 03:58 PM IST

      Cipla Q1 Preview | Profit may decline 10% YoY on flat revenue

      Brokerages expect a decline in domestic sales due to a high base of last year but a healthy YoY growth in the US, Europe and South Africa

    • Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates May 10, 2022 08:09 PM IST

      Cipla Q4 results | Profit declines 12% YoY to Rs 362 crore; revenue rises to Rs 5,260 crore, misses estimates

      Cipla’s One-India business continued the double digit trajectory during the quarter. As it crossed the $1 billion milestone in the domestic branded prescription business driven by the sustained growth across our acute and chronic portfolio

    • Cipla Results Preview | Consolidated net profit may rise 47% on India ops May 10, 2022 12:14 PM IST

      Cipla Results Preview | Consolidated net profit may rise 47% on India ops

      The company will report its March quarter numbers later today

    • Pharma Q4 Preview | Despite strong domestic demand and modest US growth, cost pressure, lower prices to dent margins April 18, 2022 03:11 PM IST

      Pharma Q4 Preview | Despite strong domestic demand and modest US growth, cost pressure, lower prices to dent margins

      Raw material prices aggravated due to COVID-led lockdowns in China and spike in logistics costs to overshadow revenue growth

    • Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore January 25, 2022 07:11 PM IST

      Cipla Q3 results | Profit falls 2.6% YoY to Rs 729 crore, revenue grows to Rs 5,479 crore

      A lower contribution from COVID-related drugs dented the performance in the domestic market but a healthy growth in overseas markets provided the much-needed cushion.

    • Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability January 25, 2022 07:45 AM IST

      Cipla Q3 Results Preview | Decline in domestic business likely to impact profitability

      A growth of 2-3 percent is seen in revenue but profit is expected to decline 7-12 percent on-year.

    • Cipla Q2 Result | Profit rises 7% YoY to Rs 711 crore, revenue up 10% at Rs 5,520 crore October 26, 2021 08:20 PM IST

      Cipla Q2 Result | Profit rises 7% YoY to Rs 711 crore, revenue up 10% at Rs 5,520 crore

      Revenues were aided by brisk business in the domestic and US formulations space for the company as well as in other parts of the world.

    • Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts October 26, 2021 07:15 AM IST

      Cipla Q2 Results Preview: Topline likely to increase 4%, bottomline 6%, say experts

      Investors would look at the outlook for limited competition pipeline in the US, decision on Avenue Therapeutics and update on inhaler products for the US

    • Buy Cipla Limited; target of Rs 653: Khambatta Securities August 23, 2017 06:11 PM IST

      Buy Cipla Limited; target of Rs 653: Khambatta Securities

      Khambatta Securities is bullish on Cipla Limited has recommended buy rating on the stock with a target price of Rs 653 in its research report dated August 14, 2017.

    • Cipla to buy control of S. Africa's Cipla Medpro November 21, 2012 03:52 PM IST

      Cipla to buy control of S. Africa's Cipla Medpro

      Indian drugs maker Cipla Limited has offered to buy a about a 51 percent stake in South Africa's Cipla Medpro , to strengthen its position in the fast-growing African drugs market.